Institutional Ownership
Syndax Pharmaceuticals Inc
CUSIP 87164F105COMSNDXQ1 2026
Institutional Holders
237
13F filers
Shares Held
92.97M
Aggregate institutional
Institutional Value
$2.14B
Q1 2026
Net New Holders
+14
39 new · 25 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions39
Increased99
Decreased66
Sold out25
Institutional Holders
237 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | 8.25M | $192.82M | +15.4K | Added |
| 2 | Kynam Capital Management, LP | 8.05M | $188.07M | 0 | Held |
| 3 | Goldman Sachs Group Inc | 5.00M | $116.72M | −698.6K | Reduced |
| 4 | State Street Corp | 4.43M | $103.49M | −166.5K | Reduced |
| 5 | Bank Of America Corp /De/ | 4.25M | $99.28M | −460.9K | Reduced |
| 6 | Deerfield Management Company, L.P. | 3.78M | $88.30M | +3.78M | New |
| 7 | Eversept Partners, LP | 2.89M | $67.41M | −428.8K | Reduced |
| 8 | Kingdon Capital Management, L.L.C. | 2.50M | $58.40M | +150.0K | Added |
| 9 | Hood River Capital Management LLC | 2.35M | $55.00M | +37.7K | Added |
| 10 | Geode Capital Management, LLC | 2.16M | $50.40M | +66.1K | Added |
227 more institutional holders on Premium
See every fund holding Syndax Pharmaceuticals Inc, with full quarter-over-quarter share changes.
Unlock all holders